# Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck

> **NCT00184028** · PHASE2 · TERMINATED · sponsor: **University of Southern California** · enrollment: 12 (actual)

## Conditions studied

- Carcinoma of the Head and Neck

## Interventions

- **DRUG:** Taxotere
- **DRUG:** Oxaliplatin

## Key facts

- **NCT ID:** NCT00184028
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** 2009-07
- **Final completion:** 2010-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Insufficient Accrual
- **Last updated:** 2014-05-22

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00184028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00184028, "Combination of Taxotere and Oxaliplatin in Squamous Cell Carcinoma of the Head and Neck". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00184028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*